102 filings
Page 3 of 6
8-K
pn5m2gyjd55lcdd
7 Mar 19
Kadmon Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results
4:19pm
8-K
pe6wbki 17v6t5meeo
11 Feb 19
Kadmon Announces Appointment of Steven Meehan as CFO
4:16pm
8-K
78y4wqqr9i4s97r9w3
7 Feb 19
Kadmon Announces Appointment of David E. Cohen, M.D., MPH, to Board of Directors
4:16pm
8-K
gjs 0sag6i
5 Feb 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:15pm
8-K
3edil9swbab9s4p
23 Jan 19
Kadmon Announces Appointment of Cynthia Schwalm to Board of Directors
4:16pm
8-K
l30lec4uagd yg9
27 Dec 18
Departure of Directors or Certain Officers
4:17pm
8-K
hqb5dp
3 Dec 18
Kadmon Announces Updated Findings from Ongoing Phase 2 Clinical Trial of KD025 in cGVHD at ASH Annual Meeting
10:08am
8-K
m3g5a
9 Nov 18
Kadmon Provides Business Update and Reports Third Quarter 2018 Financial Results
4:22pm
8-K
n79tuxq4iz
25 Oct 18
Other Events
9:00am
8-K
bmhha 6ov32p4n
24 Oct 18
Kadmon Announces CFO Transition and Other Updates
4:16pm
8-K
9cakhktx h3g
17 Oct 18
Other Events
9:03am
8-K
31hr3 ov8ms75z6dwre
16 Aug 18
Entry into a Material Definitive Agreement
4:08pm
8-K
ggw7en883ih2swg
9 Aug 18
Kadmon Provides Business Update and Reports Second Quarter 2018 Financial Results
12:00am
8-K
rs0l7drrv2h ooc
27 Jul 18
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
65sbd npl55
14 Jun 18
Kadmon Announces Pricing of Offerings of Common Stock
12:00am
8-K
ekb20q
13 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
dkg47
11 Jun 18
Kadmon Announces Proposed Public Offering of Common Stock
4:09pm
8-K
7ugps77
29 May 18
Departure of Directors or Certain Officers
4:20pm
8-K
tvq78seadawk kn
23 May 18
Departure of Directors or Certain Officers
4:16pm
8-K
y1fazc8z17u
8 May 18
Kadmon Provides Business Update and Reports First Quarter 2018 Financial Results
4:26pm